AXA Framlington Biotech Fund - Z Acc
Asset allocation %
Morningstar style box TM
Equity style
SizeLarge
Mid
Small
Value
Blend
Growth
Style
Size
| Share class size (mil) | 296 GBP (19/11/2026) |
| Fund size (mil) | 344 GBP (30/09/2026) |
Top 10 holdings
| Assets in top 10 holdings % | 53.03 |
| Total number of equity holdings | 52 |
| Total number of bond holdings | 0 |
| Holdings 31/10/2026 | % of assets |
|---|---|
| Vertex Pharmaceuticals Inc | 8.70 |
| Amgen Inc | 8.12 |
| Regeneron Pharmaceuticals Inc | 7.55 |
| Gilead Sciences Inc | 6.90 |
| argenx SE ADR | 4.71 |
| United Therapeutics Corp | 4.19 |
| Revolution Medicines Inc Ordinary Shares | 4.05 |
| Insmed Inc | 3.73 |
| BeOne Medicines Ltd ADR | 2.65 |
| Mirum Pharmaceuticals Inc | 2.43 |